ImmunityBio (IBRX) Change in Intangibles (2015 - 2022)

ImmunityBio (IBRX) reported Change in Intangibles of $21.2 million for Q1 2022, up 6307.31% quarter-over-quarter from -$342000.0 in Q3 2015.

ImmunityBio (IBRX) Change in Intangibles (2015 - 2022) Analysis & Trends

ImmunityBio (IBRX) has 2 years of Change in Intangibles data on file, last reported at $21.2 million in Q1 2022.

Change in Intangibles for Q1 2022 came in at $21.2 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2022 was $21.2 million (changed N/A YoY), and the FY2022 annual result was $21.2 million, changed N/A from the prior year.
Change in Intangibles climbed to $21.2 million in Q1 2022 per IBRX's latest filing, from -$342000.0 in the prior quarter.
Over five years, Change in Intangibles peaked at $21.2 million in Q1 2022 and troughed at $21.2 million in Q1 2022.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Change in Intangibles (Qtr)
1	Alterity Therapeutics	925,601.88 Bn	925,601.85 Bn	-	-
2	Belite Bio	58,560.00 Bn	58,560.00 Bn	-	-
3	Quantum Biopharma	17,284.41 Bn	17,284.40 Bn	-	-2.96 Mn
4	Legend Biotech	2,809.00 Bn	2,808.71 Bn	242.10 Mn	-
5	Evaxion A	1,334.43 Bn	1,334.42 Bn	-	-
6	Akari Therapeutics	1,312.27 Bn	1,312.26 Bn	-	-
7	Psyence Biomedical	212.16 Bn	212.16 Bn	-	-
8	Vertex Pharmaceuticals	114.83 Bn	107.58 Bn	2.59 Bn	-
9	Abivax	91.96 Bn	91.96 Bn	-	-
10	ImmunityBio	7.55 Bn	7.17 Bn	43.97 Mn	-

Download Data